Is BridgeBio Pharma, Inc. technically bullish or bearish?

As of 26 September 2025, the technical trend for BridgeBio Pharma, Inc. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are both bullish, supporting a positive outlook. The daily moving averages also indicate a bullish stance. However, the Dow Theory presents a mixed view with a weekly signal of mildly bearish and a monthly signal of mildly bullish. The Bollinger Bands are mildly bullish on both weekly and monthly time frames, while the KST is bullish in both periods.
In terms of performance, the stock has shown strong returns over multiple periods, with a year-to-date return of 82.40% compared to the S&P 500's 12.96%, and a one-year return of 104.45% versus the S&P 500's 15.64%. Overall, the current technical stance is bullish, driven primarily by the MACD and moving averages.